Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs SK Telecom Co. Ltd. Common Stock (SKM) Price & Performance

GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.

The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.

SKM trades at $34.42, up 2.9% today, showing strong earnings momentum with three consecutive quarterly beats. The stock faces technical headwinds with a bearish moving average signal despite oversold RSI conditions. Fundamentally, the company demonstrates robust gross margins of 87.51% but modest net income margins of 4.38%, with recent AI data center spin-offs creating potential value catalysts.

Outlook remains balanced with analyst consensus divided (42.85% Buy, 42.86% Hold) amid AI infrastructure expansion opportunities. Key risks include negative cash flow trends and competitive pressures in wireless communications. The current valuation at 24.39 P/E appears reasonable given growth initiatives, but execution on data center strategy will determine future performance.